Article Versions Notes

Jotterand V, Jagannath V, Diaz AA, Velez JD, Letica A, Perez SN, Clark R, Caraco Y, Degen O, Park K-H, et al. A Phase 3 Randomized Trial Investigating the Safety, Tolerability, and Immunogenicity of V116, an Adult-Specific Pneumococcal Vaccine, Compared with PPSV23, in Adults ≥50 Years of Age (STRIDE-10). Vaccines. 2025; 13(4):341. https://doi.org/10.3390/vaccines13040341

Jotterand, Veronika, Vinita Jagannath, Andrea Accini Diaz, Juan Diego Velez, Arna Letica, Silvia Narejos Perez, Rebecca Clark, Yoseph Caraco, Olaf Degen, Kyung-Hwa Park, and et al. 2025. "A Phase 3 Randomized Trial Investigating the Safety, Tolerability, and Immunogenicity of V116, an Adult-Specific Pneumococcal Vaccine, Compared with PPSV23, in Adults ≥50 Years of Age (STRIDE-10)" Vaccines 13, no. 4: 341. https://doi.org/10.3390/vaccines13040341

Jotterand, V., Jagannath, V., Diaz, A. A., Velez, J. D., Letica, A., Perez, S. N., Clark, R., Caraco, Y., Degen, O., Park, K.-H., Ünal, S., Wittke, F., Hurtado, K., Churchill, C., Zhang, Y., Fernsler, D., Li, J., Buchwald, U. K., & Platt, H. (2025). A Phase 3 Randomized Trial Investigating the Safety, Tolerability, and Immunogenicity of V116, an Adult-Specific Pneumococcal Vaccine, Compared with PPSV23, in Adults ≥50 Years of Age (STRIDE-10). Vaccines, 13(4), 341. https://doi.org/10.3390/vaccines13040341